Copyright
©The Author(s) 2016.
World J Gastroenterol. Mar 7, 2016; 22(9): 2749-2759
Published online Mar 7, 2016. doi: 10.3748/wjg.v22.i9.2749
Published online Mar 7, 2016. doi: 10.3748/wjg.v22.i9.2749
Table 3 Studies comparing the effects of recipient and donor characteristics on tumor recurrence among patients with hepatocellular carcinoma after liver transplantation
Ref. | Year | Characteristics | Evaluated parameter | Recurrence rate | P value |
Recipient | |||||
Mathur et al[59] | 2014 | Overweight or obese | Overweight vs obese vs non-obese | 15% vs 15% vs 7% | < 0.050 |
Ballarin et al[70] | 2011 | Age | Elderly vs younger | 7.1% vs 4.8% | > 0.050 |
Yang et al[73] | 2014 | Gender | Male vs female | NA | NA |
Donor | |||||
Nagai et al[74] | 2014 | Ischemia times | CIT >10 h vs < 10 h and WIT > 50 min vs ≤ 50 min | NA | 0.015 |
Sharma et al[85] | 2012 | Age | Median donor age for patients with HCC recurrence vs without HCC recurrence | NA | 0.008 |
Miyagi et al[94] | 2012 | ABO-I graft | Strong imunosuppressive therapy vs other imunosuppressive therapy | NA | NA |
Teng da et al[96] | 2012 | Steatosis donor liver | Grafts with no steatosis vs mild steatosis vs moderate-to-severe steatosis | 15.8% vs 8.3% vs 33.3% at 1 yr; 28.7% vs 20.8% vs 50% at 3 yr | > 0.050 |
- Citation: Gu XQ, Zheng WP, Teng DH, Sun JS, Zheng H. Impact of non-oncological factors on tumor recurrence after liver transplantation in hepatocellular carcinoma patients. World J Gastroenterol 2016; 22(9): 2749-2759
- URL: https://www.wjgnet.com/1007-9327/full/v22/i9/2749.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i9.2749